iBio Adds New Therapeutic Antibody to Its Pipeline PharmaLive (press release) (subscription) Prior to the discovery of this influenza antibody product candidate, the collaboration has produced rituximab and palivizumab biosimilar candidates. "We are pleased to further expand our antibody product candidate pipeline, particularly with an ... |
